Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings Corporation announced a change in its Representative Directors, effective April 1, 2025, due to the retirement of a current director upon completion of their term. This leadership change is part of the company’s ongoing efforts to maintain its strategic direction and operational efficiency within the healthcare industry.
More about Alfresa Holdings
The Alfresa Group is a prominent entity in the Japanese healthcare sector, focusing on ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, and operating dispensing pharmacies. The company aims to fulfill its corporate philosophy of creating and delivering a fresh life for all. Alfresa Holdings Corporation reported consolidated revenue of ¥2.8 trillion for the fiscal year ended March 31, 2024.
YTD Price Performance: -3.61%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.66B
See more data about 2784 stock on TipRanks’ Stock Analysis page.